Metabolic Syndrome

Metabolic syndrome is a clustering of abdominal adiposity, dysglycemia, elevated blood pressure, high triglycerides, and low HDL cholesterol. The label matters because these findings do not simply coexist by chance: they usually reflect insulin resistance and dysfunctional visceral fat, and together they predict a much higher likelihood of type 2 diabetes and atherosclerotic cardiovascular disease. A patient may look well while this process is advancing. The experienced nurse notices the pattern: a steadily increasing waist circumference, borderline fasting glucose, blood pressure that is “not that high,” triglycerides above goal, and low HDL cholesterol. None may be dramatic alone. Their combination signals a patient whose cardiometabolic risk needs active intervention rather than reassurance. Metabolic syndrome roughly doubles a person’s 5- to 10-year risk of atherosclerotic cardiovascular disease and raises the risk of type 2 diabetes about fivefold. It does not replace a formal cardiovascular risk calculation, diabetes evaluation, or assessment for other causes of dyslipidemia and hypertension.